ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Internal Medicine

Top Internal Medicine Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VIRGINIA PASCUAL M.D.

Internal Medicine

444

$102K

73
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$231
Average prescription price

Avg: $54

CHERYL COOK MD

Internal Medicine

575

$22.9K

251
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $54

MARK WARD D.O.

Internal Medicine

632

$31.3K

127
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $54

DANIEL SHORT D.O.

Internal Medicine

640

$35.9K

64
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $54

AMY FISHBURN MD

Internal Medicine

749

$34.4K

138
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $54

DENISE MEHIA MD

Internal Medicine

886

$49.2K

56
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $54

EDWARD THOMAS M.D.

Internal Medicine

931

$53.3K

29
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $54

JAMES ATTARIAN MD

Internal Medicine

966

$31.5K

155
134 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $54

SCOTT WOLLER M.D.

Internal Medicine

974

$156K

131
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$160
Average prescription price

Avg: $54

TERENCE HANKINS D.O.

Internal Medicine

1,231

$52.8K

190
141 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $54

LAUREL DESNICK MD

Internal Medicine

1,385

$50.5K

187
160 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 22%

$36
Average prescription price

Avg: $54

JANICE GRIFFIN MD

Internal Medicine

1,464

$95K

136
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $54

PAUL BERKRAM M.D.

Internal Medicine

1,670

$69.3K

205
166 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $54

MARK GOBIN DO

Internal Medicine

2,012

$128K

245
190 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $54

ARTHUR FINK D.O.

Internal Medicine

2,038

$89.3K

132
114 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $54

HUGH HUGHSON MD

Internal Medicine

2,102

$134K

215
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $54

MECHELLE LEWIS M.D.

Internal Medicine

2,303

$104K

178
140 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $54

BRYAN WEBB MD

Internal Medicine

2,387

$68.4K

318
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$29
Average prescription price

Avg: $54

VICTORIA WANG M.D.

Internal Medicine

2,406

$135K

77
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $54

THOMAS KELLY MD

Internal Medicine

2,533

$160K

196
161 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $54

JANELLE DONOVAN MD

Internal Medicine

2,586

$136K

228
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $54

STEFFAN MAY M.D.

Internal Medicine

2,703

$143K

174
133 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $54

DAVID CRITES MD

Internal Medicine

2,981

$163K

252
186 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $54

DOUGLAS SWIFT MD

Internal Medicine

3,110

$149K

236
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $54

JEAN JUSTAD MD

Internal Medicine

3,195

$192K

114
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank